That's probably a long shot as they will likely not get approval and may shelve it, but I guess your thought is it may be used to weed out the negative cases first and only follow up with the complex and more dangerous ITT for confirmation if positive or inconclusive. Not sure if that's feasible, maybe they can pitch it. For now it's Zoptrex or bust.
News 
Market Data 
Discover 
